We are live on ! Find out more
WHWK

Whitehawk Therapeutics
WHWK

39 hedge funds and large institutions have $54.6M invested in Whitehawk Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less capital invested

Capital invested by funds: $56.4M → $54.6M (-$1.76M)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

22% less funds holding

Funds holding: 50 → 39 (-11)

66.31% less ownership

Funds ownership: 128.79% → 62.48% (-66%)

85% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 13

Holders
39
Holders Change
-11
Holders Change %
-22%
% of All Funds
0.51%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
9
Reduced
11
Closed
13
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$60K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$956K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$238K
3
QF
QVT Financial
New York
+$174K
4
Jane Street
Jane Street
New York
+$137K
5
Squarepoint
Squarepoint
New York
+$107K

Top Sellers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
-$3.36M
2
EC
EcoR1 Capital
California
-$1.72M
3
SFA
Semmax Financial Advisors
North Carolina
-$145K
4
Citadel Advisors
Citadel Advisors
Florida
-$120K
5
Morgan Stanley
Morgan Stanley
New York
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$7.66K +$2.69K +1,543 +60%
US Bancorp
27
US Bancorp
Minnesota
$6.23K – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$5.74K -$57 -33 -1%
Morgan Stanley
29
Morgan Stanley
New York
$3.75K -$108K -62,234 -97%
BCWM
30
Bartlett & Co Wealth Management
Ohio
$2.49K – – –
JP Morgan Chase
31
JP Morgan Chase
New York
$787 -$2.33K -1,341 -76%
Bank of America
32
Bank of America
North Carolina
$769 +$402 +231 +128%
Russell Investments Group
33
Russell Investments Group
United Kingdom
$722 -$1.96K -1,126 -74%
Federated Hermes
34
Federated Hermes
Pennsylvania
$669 -$996 -572 -62%
TWC
35
TD Waterhouse Canada
Ontario, Canada
$432 – – –
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$299 – – –
SS
37
SBI Securities
Japan
$36 -$2 -1 -5%
PA
38
Parallel Advisors
California
$15 – – –
BCM
39
BML Capital Management
Indiana
– -$3.36M -1,890,245 Closed
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
– -$93.4K -52,486 Closed
SCM
41
Stonepine Capital Management
Oregon
– -$83.1K -46,698 Closed
Millennium Management
42
Millennium Management
New York
– -$79.8K -44,823 Closed
Two Sigma Investments
43
Two Sigma Investments
New York
– -$76.8K -43,158 Closed
Two Sigma Advisers
44
Two Sigma Advisers
New York
– -$72.9K -40,969 Closed
SG Americas Securities
45
SG Americas Securities
New York
– -$65K -36,774 Closed
Prudential Financial
46
Prudential Financial
New Jersey
– -$38.8K -21,800 Closed
PCM
47
Prelude Capital Management
New York
– -$18.2K -10,197 Closed
SFA
48
Semmax Financial Advisors
North Carolina
– -$145K -297 Closed
Citigroup
49
Citigroup
New York
– -$134 -75 Closed
Wells Fargo
50
Wells Fargo
California
– -$59 -33 Closed
1
2
3

WHWK Hedge Fund Activity: Q2 2025 in Review

39 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q2 2025, worth a combined $54.6M — down 3.1% from $56.4M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of WHWK and 2 opened new positions — a net loss of 11 holders — while 11 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $956K. The largest seller was BML Capital Management, exiting entirely with an estimated $3.36M sold.

  • 39 institutional investors held Whitehawk Therapeutics (WHWK) as of Q2 2025, down from 50 in Q1 2025.
  • Funds reported $54.6M of Whitehawk Therapeutics stock for Q2 2025, down 3.1% quarter-over-quarter.
  • 2 funds opened new Whitehawk Therapeutics positions in Q2 2025 and 13 closed out, a net change of -11 holders.
  • The largest Whitehawk Therapeutics buyer in Q2 2025 was Vanguard Group, an estimated $956K added.
  • The largest Whitehawk Therapeutics seller in Q2 2025 was BML Capital Management, an estimated $3.36M sold.

Based on aggregated 13F filings for Q2 2025.